MEDIKAMENTENABGABEVORRICHTUNG

European patent · EP3484549 · In force

Register entry

Publication number
EP3484549
Application number
EP17754267
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jul 12, 2017
Published
May 22, 2019
Granted
Dec 30, 2020
Protection ends at the latest
Jul 11, 2037
Next annual fee due
Jul 31, 2027
IPC classes
A61M 5/20 (2006.01)
A61M 5/32 (2006.01)
A61M 5/24 (2006.01)
Priority
EP 16305915 14.07.2016
PCT application
PCT/EP2017/067512 12.07.2017
PCT publication
WO2018/028915 15.02.2018
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.07.2026 → 31.07.2027

    Published in Swissreg on 01.08.2026

  2. Aug 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.07.2025 → 31.07.2026

    Published in Swissreg on 01.08.2025

  3. Aug 1, 2024

    Change

    Published in Swissreg on 01.08.2024

  4. Aug 1, 2023

    Change

    Published in Swissreg on 01.08.2023

  5. Aug 1, 2022

    Change

    Published in Swissreg on 01.08.2022

  6. Nov 10, 2021

    Change

    Published in Swissreg on 10.11.2021

  7. Dec 30, 2020

    Granted

    Published in Swissreg on 30.12.2020

Parties

Holder

SANOFI

Sanofi

54, rue La Boétie, 75008 Paris, FR

Inventor

PRADEL, Giuliano

20842 Besana in Brianza (MB), IT

FRANKE, Beate

65926 Frankfurt am Main, DE

NELSON, Andrew

Dallas, Texas 75220, US

SCHABBACH, Michael

65926 Frankfurt am Main, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.